The Vagal Nerve Stimulation (VNS) market is booming, with a CAGR of 9.5% and projected to surpass $1 billion by 2025. Explore market trends, key players (Medtronic, Boston Scientific), regional analysis, and future growth projections in this comprehensive report. Learn about VNS therapy for epilepsy, depression, and heart failure.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.